Your browser doesn't support javascript.
loading
A Disintegrin and A Metalloproteinase-9 (ADAM9): A Novel Proteinase Culprit with Multifarious Contributions to COPD.
Wang, Xiaoyun; Polverino, Francesca; Rojas-Quintero, Joselyn; Zhang, Duo; Sánchez, José; Yambayev, Ilyas; Lindqvist, Eva; Virtala, Robert; Djukanovic, Ratko; Davies, Donna E; Wilson, Susan; O'Donnell, Rory; Cunoosamy, Danen; Hazon, Petra; Higham, Andrew; Singh, Dave; Olsson, Henric; Owen, Caroline A.
Afiliação
  • Wang X; Brigham and Women's Hospital, 1861, Boston, Massachusetts, United States.
  • Polverino F; Brigham and Women's Hospital, Harvard Medical School, Medicine, Boston, Massachusetts, United States.
  • Rojas-Quintero J; Brigham and Women's Hospital, Harvard Medical School, Medicine, Boston, Massachusetts, United States.
  • Zhang D; Boston University, 1846, Boston, Massachusetts, United States.
  • Sánchez J; AstraZeneca R&D, Quantitative Biology, Discovery Sciences, Gothenburgh, Sweden.
  • Yambayev I; Brigham and Women's Hospital, 1861, Boston, Massachusetts, United States.
  • Lindqvist E; AstraZeneca R&D , Department of Translational Biology, Respiratory, Inflammation & Autoimmunity IMED, Gothenburg, Sweden.
  • Virtala R; AstraZeneca R&D , Department of Translational Biology, Respiratory, Inflammation & Autoimmunity IMED, Gothenburg, Sweden.
  • Djukanovic R; Southampton University, Clinical and Experimental Sciences and Southampton NIHR Respiratory Biomedical Research Unit, Southampton, United Kingdom of Great Britain and Northern Ireland.
  • Davies DE; Brooke Laboratory, Infection, Inflammation & Repair, Southampton, Hampshire, United Kingdom of Great Britain and Northern Ireland.
  • Wilson S; University of Southampton, 7423, Southampton, United Kingdom of Great Britain and Northern Ireland.
  • O'Donnell R; St. James's Hospital, Dublin, Isle of Man.
  • Cunoosamy D; AstraZeneca, Respiratory, Inflammation and Autoimmune iMed, Molndal, Sweden.
  • Hazon P; AstraZeneca R&D , Department of Translational Biology, Respiratory, Inflammation & Autoimmunity IMED, Gothenburg, Sweden.
  • Higham A; University of South Manchester NHS Foundation Trust, Medicines Evaluation Unit, Manchester, United Kingdom of Great Britain and Northern Ireland.
  • Singh D; North West Lung Research Centre, Manchester, United Kingdom of Great Britain and Northern Ireland.
  • Olsson H; AstraZeneca R&D , Department of Translational Biology, Respiratory, Inflammation & Autoimmunity IMED, Gothenburg, Sweden.
  • Owen CA; Brigham and Women's Hospital, Boston, Massachusetts, United States ; cowen@rics.bwh.harvard.edu.
Am J Respir Crit Care Med ; 2018 Jun 04.
Article em En | MEDLINE | ID: mdl-29864380
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article